Skip to main content
Premium Trial:

Request an Annual Quote

Huntsman Cancer Institute Taps Linguamatics Software to Mine EMRs

Premium

Linguamatics said this week that researchers at the University of Utah's Huntsman Cancer Institute are using Linguamatics I2E, the company's text mining software solution, to extract information from electronic health records that could help them better understand cancer and improve treatments.

According to the company, HCI is using I2E to "extract discrete data from the unstructured text contained in surgical, pathology, radiology, and clinical notes related to hematology oncology disease areas such as leukemia and lymphoma." By combining this data with other sources of information including genomic data, HCI's scientists are able to investigate patient outcomes and genetic drivers of disease as well as conduct comparative effectiveness studies, the company said.

The financial details of the licensing agreement were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.